Acetylcholinesterase: A gorge-ous enzyme
It’s always said “Don’t shoot the messenger”, but if the messenger keeps delivering the same message, he quickly becomes irritating! It is the job of the enzyme acetylcholinesterase (AChE) to ‘shoot the messenger’ at the neuromuscular junction, the point of contact between the nervous system and the muscles. This enzyme splits the neurotransmitter acetylcholine into acetate and choline (fig. 1) in order to prevent its accumulation, which would lead to repeated and uncontrolled muscle stimulation. Acetylcholine was the first neurotransmitter to be identified, earning Dale and Loewi the 1936 Nobel Prize in Physiology or Medicine. AChE is such a key enzyme that it is a target for chemical weapons, pest-control agents, drugs, and even snake venoms.
AChE is an efficient enzyme, catalysing the breakdown of up to 10,000 acetylcholine molecules per second. The first structure of AChE (PDB entry 1ace) was from the electric ray Torpedo californica, which has large amounts of AChE in its electric organ. It revealed that the active site is not on the protein’s surface but at the bottom of a 20Å deep gorge (view-1) lined with many aromatic residues. Even though the acetylcholine substrate is positively charged (fig. 1), there are few negatively charged residues in the gorge.
Gorge-ous interactionsBefore the structure was solved, it was known that there were two binding sites for the positively charged (cationic) substrate, which were termed anionic sites. The structure showed that these sites both lie within the gorge but neither is actually anionic. They are formed by a group of aromatic residues, predominantly tryptophans. The ‘peripheral anionic site’ (PAS; view-1) lies at the entrance to the gorge and sequesters acetylcholine. Acetylcholine forms a with the tryptophan, and the carbonyl of the acetyl group forms a weak hydrogen bond to a tyrosine further down the gorge. Acetylcholine, or the substrate analogue acetylthiocholine (PDB entries 2ha4, 2c4h, 2c58), is only observed at this site when high concentrations were present in the crystallisation solution, indicating that the PAS is only occupied transiently.
At the base of the gorge, a second tryptophan plays a key role in the ‘catalytic anionic site’ (CAS). Again, acetylcholine forms a π-cation interaction between its quaternary amine and the tryptophan ring. The acetyl group is bound in the acyl pocket, formed from further aromatic residues lining the base of the gorge.
Between the two anionic sites, the gorge narrows due to a constriction formed by two aromatic sidechains (view-1). The constriction is smaller than acetylcholine, indicating that the protein must undergo considerable conformational changes locally to widen the gorge and let the substrate through.
Triad catalysisBinding in the CAS and acyl pocket locates acetylcholine at the active site of the enzyme (view-2). Three amino acids, glutamate, histidine and serine, known as a catalytic triad, form this site which is common in protease enzymes. These residues are arranged in such a way that the histidine and glutamate donate electrons to the serine, making it reactive. The serine is able to form a covalent bond with acetylcholine, reducing its carbon-oxygen double bond (fig 1). This species is termed the tetrahedral intermediate, in which the oxygen is charged. This ‘oxyanion’ is stabilised by interactions with backbone amide groups in an area termed the ‘oxyanion hole’. (view-2). From this intermediate, the acetyl-choline bond is broken, releasing choline and leaving acetyl-serine. The serine-acetate bond is then hydrolysed by water to release acetate and regenerate the enzyme.
Because the active site is so deep within the protein, the substrate is almost totally surrounded by protein, leading to stabilisation of the intermediate and the rapid catalytic rate.
Weapon of mass destructionThe banned nerve agent sarin (fig. 1) is a potent inhibitor of AChE. It is a highly volatile liquid that reacts rapidly with the active-site serine of AChE (PDB entries 2y2v and 2whp), displacing the fluorine and forming an oxygen-phosphorus bond (view-2) that cannot be hydrolysed. The catalytic serine is thus irreversibly modified and the enzyme inactivated. Sarin and similar organophosphorous nerve agents cause death by asphyxiation as acetylcholine accumulates in the neuromuscular junction and the muscles around the lungs go into spasm.
Some insecticides, such as fenamiphos (e.g., PDB entries 2jgf, 2wu3, 2wu4) and malathion, are also organophosphates and act in the same way as sarin. These insecticides have varying levels of toxicity to humans; in fact, malathion is used to treat head lice! However, as is the case with sarin, exposure to sublethal doses can lead to permanent neurological problems.
Drugs: Making a little go a long way.Several drugs which inhibit AChE, some derived from plants, are used clinically to treat the symptoms of dementia. In diseases such as Alzheimer’s, certain types of brain cell produce too little acetylcholine, which they use as a neurotransmitter. Inhibiting AChE means that what little neurotransmitter is produced can deliver its message more times before it is broken down. The side-effects of these drugs include nausea and vomiting (also symptoms of sublethal sarin poisoning) so it is easy to see why they act as a plant defence against herbivores.
Rivastigmine (fig. 1), derived from the Calabar bean alkaloid physostigmine, reacts with the active-site serine in AChE (PDB entry 1gqr) leaving a carbamate group attached (view-3). Unlike sarin, rivastigmine is a relatively slow inhibitor of AchE, so the drug does not kill the patient! The cleaved portion of the drug also remains bound through an aromatic ring-stacking interaction with the CAS tryptophan.
Other drugs block the active site but do not react with the enzyme. Huprine (e.g., PDB entries 1e66, 4bdw) is a synthetic derivative of huperzine (PDB entries 1vot, 1gpk, 4ey5), extracted from a moss which has been used in Chinese medicine for centuries. Galanthamine (e.g., PDB entries 1w6r, 4ey6), first isolated from snowdrops (Galanthus sp), is a bulky molecule like huperzine. It interacts with both the PAS and the acyl-binding pocket (view-3), competing with acetylcholine for the active site. Galanthamine is also taken to promote lucid dreams and out-of-body experiences, but whether its anti-cholinesterase activity or some other property causes these effects is not known.
Tacrine (PDB entry 1acj) is a synthetic molecule that binds only to the CAS (view-3) and does not interact with residues around the active site. Donepezil (also known as aricept) is bivalent, interacting with both the CAS and PAS tryptophans (view-3) via ring-stacking interactions (PDB entries 4ey7, 1eve). Donezepil is a 20-fold more potent inhibitor of AChE than tacrine. In the USA alone, the market for donezepil was $2.5 billion in 2010.
Snake venomThe venom from some snakes contains the protein fasciculin, so called because it causes fasciculation (involuntary muscle twitches) in the snake’s prey. Fasciculin targets AChE, contributing to immobilisation of the imminent meal. It inhibits AChE by binding at the top of the gorge (e.g., PDB entries 1fss, 1b41, 2x8b) and plugging it (view-4). Fasciculin is described as a three-fingered protein and two of the fingers hold on to the rim of the gorge. Finger 1 lies on the outer surface of the enzyme while finger 2 interacts with residues of the PAS within the gorge. Whilst there are some interchain hydrogen-bonds, the interaction between the two proteins is largely hydrophobic. Unusually, a methionine sidechain stacks with the tryptophan ring of the PAS (view-4). The surface of fasciculin is complementary in shape to that of AChE, burying over 2000 Å2 of surface when the proteins come together. While there are no salt bridges between the two proteins, it has been noted that the dipole moments of the two proteins are approximately aligned (ref. 1). which may also aid in binding.
AChE: a target of many different moleculesAChE is an essential component of the nervous system. Some snakes have found a way to inhibit this enzyme to help immobilise their prey, and some plants have molecules which inhibit it just enough to discourage animals from eating them. Mankind has targeted AChE in the treatment of disease, to kill pests, and also to kill other humans. The 2009 IgNobel Prize in Public Health was awarded for a means of avoiding chemical weapons, presumably including sarin which targets AChE, whilst the 2013 Nobel Peace Prize was awarded to the Organisation for the Prohibition of Chemical Weapons "for its extensive efforts to eliminate chemical weapons."
Further explorationYou can explore the many structures of acetylcholinesterase in the PDB archive using the PDBe Enzyme Browser.